• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Harrow Inc (NQ: HROW )

    10.49 +0.06 (+0.58%)
    Streaming Delayed Price Updated: 10:55 AM EDT, May 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 40,361
    Open 10.69
    Bid (Size) 10.49 (3)
    Ask (Size) 10.53 (4)
    Prev. Close 10.43
    Today's Range 10.37 - 10.79
    52wk Range 7.600 - 28.25
    Shares Outstanding 35,362,642
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
    From Harrow, Inc.
    Via Business Wire
    Around $2M Bet On This Industrial Stock? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga

    Performance

    YTD
    -12.22%
    -12.22%
    1 Month
    -18.05%
    -18.05%
    3 Month
    +10.07%
    +10.07%
    6 Month
    -22.01%
    -22.01%
    1 Year
    -59.04%
    -59.04%

    More News

    Read More
    Over $24M Bet On RXO? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
    From Melt Pharmaceuticals, Inc.
    Via Business Wire
    Insiders Buying Greenwich LifeSciences And 2 Other Stocks
    Via Benzinga
    Harrow: Q4 Earnings Insights
    Via Benzinga
    Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    INTC Stock Alert: Intel Just Got a Major $8.5 Billion Boost
    Via InvestorPlace
    Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today?
    Via InvestorPlace
    Earnings Preview: Harrow Health
    Via Benzinga
    Why Is Harrow (HROW) Stock Up 5% Today?
    Via InvestorPlace
    Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
    From Harrow, Inc.
    Via Business Wire
    Earnings Scheduled For March 19, 2024
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
    From Harrow, Inc.
    Via Business Wire
    Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
    From Harrow, Inc.
    Via Business Wire
    Harrow Announces New Appointments to its Board of Directors
    From Harrow, Inc.
    Via Business Wire
    Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease
    From Harrow, Inc.
    Via Business Wire
    Melt Pharmaceuticals Provides Corporate Update
    From Melt Pharmaceuticals, Inc.
    Via Business Wire
    Harrow Partners with Leading Healthcare Market Access Technology Platforms
    From Harrow, Inc.
    Via Business Wire
    7 Short-Squeeze Stocks That Are Screaming for Speculation
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.